MDSpire - Takeaway
FDA & Government News

FDA Approves TECNIS PureSee IOL for Cataract Surgery

First FDA-approved extended depth of focus (EDOF) IOL maintaining contrast sensitivity comparable to an aspheric monofocal IOL

  • March 23, 2026

  • 2 min

Share

  • 1

    TECNIS PureSee IOL approved by the FDA for cataract surgery.

  • 2

    Targets both cataract-related vision loss and presbyopia.

  • 3

    Expected availability in the US later this year.

  • 4

    First EDOF IOL without loss of contrast sensitivity warning.

  • 5

    97% of patients report no bothersome visual disturbances post-surgery.

  • 6

    Combines advanced optics and proprietary materials.

  • 7

    Reduces reliance on glasses for vision correction.

Original Source(s)

FDA Approves TECNIS PureSee IOL for Cataract Surgery

  • March 23, 2026

Related Content

Virtual Reality Tests Vision Therapy

Researchers evaluate immersive training for pediatric exotropia.

VIS-101 Shows Activity in nAMD Study

Data from a phase 2a study in China suggest visual acuity gains and potential treatment durability

  • March 23, 2026

  • 2 min
The European Myopia Network

A collaborative platform for myopia experts in Europe